Arsani William sold $3.5M of DSGN
director at Design Therapeutics, Inc.. 814,874 shares at an average of $4.25, traded Aug 9, 2024, filed Aug 12, 2024.
Score components
- +15RoleDirector
- +25Trade size$3.5M at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +22.8%, 3m +55.5%, 6m +0.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-021086, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 9, 2024 | SOpen-market sale Common Stockindirect: By Logos SPV I LP | -814,874 | $4.25 | $3.5M | 0 | Aug 12, 2024 |
Related signals
Other insiders at Design Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | DSGNsell Design Therapeutics, Inc. | Arsani William director | $3.0M 562,627 shares | -19% | |
| 20Weak | DSGNsell Design Therapeutics, Inc. | Deepa Prasad director | $24k 3,806 shares | -16% | |
| 39Weak | Design Therapeutics, Inc. | Heather A. Berger director | $4,866 1,300 shares | - | |
| 49Moderate | Design Therapeutics, Inc. | John P. Schmid director | $100k 26,965 shares | - | |
| 69Notable | Design Therapeutics, Inc. | Joao Siffert MD President and CEO | $63k 7,450 shares | +6% | |
| 58Moderate | Design Therapeutics, Inc. | SR One Capital Fund I Aggregator LP owner | $7.6M 900,000 shares | +16% | |
| 66Notable | Design Therapeutics, Inc. | Simeon George director, owner | $7.6M 900,000 shares | +16% | |
| 61Notable | Design Therapeutics, Inc. | Rodney W Lappe director | $119k 15,000 shares | +15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.